Abstract
Progressive spinal muscular atrophy (SMA), the most prevalent hereditary lower motor neuron disease, is caused by mutations in the telomeric copy of the survival of motor neuron(SMN1) gene. Unlike other cells, lower motor neurons cannot tolerate low levels of smn protein. However, it is unclear as to the nature of the cell death involved. There is evidence that lower motor neurons undergo apoptosis in SMA, leading to muscle weakness and wasting. This study investigated whetherSMN1 regulation in a motor neuron model affected indices of apoptotic cell death. Decreased smn expression in neuroblas-toma hybrid (NSC-34) cell lines by small interfering RNA (siRNA) was demonstrated at the mRNA and protein level. Smn-depleted cells showed elevated caspase-3 activity, decreased cell viability and increased percentage of TUNEL positive cells. Conversely, NSC-34 cell smn overexpression by adenoviral gene transfer decreased staurosporine-induced caspase-3 elevation and mitigated induced cell toxicity as assessed by 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. However, increased smn expression by itself did not increase cell viability. These data suggest not only that decreased smn levels increase apoptosis in anin vitro model of SMA, but also that increased smn can protect against neural injury.
Similar content being viewed by others
References
Acsadi G, A Jani, B Massie, M Simoneau, P Holland, K Blaschuk and G Karpati (1994) A differential efficiency of adenovirus-mediatedin vivo gene transfer into skeletal muscle cells of different maturity.Hum. Mol. Genet. 3, 579–584.
Aran FA (1850) Recherches sur une maladie non encore décrite du systéme musculaire (atrophy musculaire progressive).Arch. Gén. Médecine 24, 172–214.
Brichta L, Y Hofmann, E Hahnen, FA Siebzehnrubl, H Raschke, I Blumcke, IY Eyupoglu and B Wirth (2003) Valproic acid increases the SMN2 protein level: a wellknown drug as a potential therapy for spinal muscular atrophy.Hum. Mol. Genet. 12, 2481–2489.
Briese M, B Esmaeili and DB Sattelle (2005) Is spinal muscular atrophy the result of defects in motor neuron processes?Bioessays 27, 946–957.
Brzustowicz LM, T Lehner, LH Castilla, GK Penchaszadeh, KC Wilhelmsen, R Daniels, KE Davies, M Leppert, F Ziter, D Woodetal. (1990) Genetic mapping of chronic childhoodonset spinal muscular atrophy to chromosome 5q11.2-13.3.Nature 344, 540–541.
Cagnoli CM, E Kharlamov, C Atabay, T Uz and H Manev (1996) Apoptosis induced in neuronal cultures by either the phosphatase inhibitor okadaic acid or the kinase inhibitor staurosporine is attenuated by isoquinolinesulfonamides H-7, H-8, and H-9.J. Mol. Neurosci. 7, 65–76.
Cashman NR, HD Durham, JK Blusztajn, K Oda, T Tabira, IT Shaw, S Dahrouge and JP Antel (1992) Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons.Dev. Dynamics 194, 209–221.
Denizot F and R Lang (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.J. Immunol. Meth. 89, 271–277.
Doran B, N Gherbesi, G Hendricks, RA Flavell, RJ Davis and L Gangwani (2006) Deficiency of the zinc finger protein ZPR1 causes neurodegeneration.Proc. Natl. Acad. Sci. USA 103, 7471–7475.
Eggert C, A Chari B Laggerbauer B and U Fischer (2006) Spinal muscular atrophy: the RNP connection.Trends Mol. Med. 12, 113–121.
Fan L and LR Simard (2002) Survival motor neuron (SMN) protein: role in neurite outgrowth and neuromuscular maturation during neuronal differentiation and development.Hum. Mol. Genet. 11, 1605–1614.
Ferri A, J Melki and AC Kato (2004) Progressive and selective degeneration of motoneurons in a mouse model of SMA.Neuroreport 15, 275–280.
Fidzianska A and J Rafalowska (2002) Motoneuron death in normal and spinal muscular atrophy-affected human fetuses.Acta Neuropathol. 104, 363–368.
Fischer U, Q Liu and G Dreyfuss (1997) The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis.Cell 90, 1023–1029.
Francis JW, AW Sandrock, PG Bhide, JP Vonsattel and RH Brown Jr (1998) Heterogeneity of subcellular localization and electrophoretic mobility of survival motor neuron (SMN) protein in mammalian neural cells and tissues.Proc. Natl. Acad. Sci. USA 95, 6492–6497.
Gangwani L (2006) Deficiency of the zinc finger protein ZPR1 causes defects in transcription and cell cycle progression.J. Biol. Chem. 281, 40330–40340.
Gangwani L, RA Flavell and RJ Davis (2005) ZPR1 is essential for survival and is required for localization of the survival motor neurons (SMN) protein to Cajal bodies.Mol. Cell. Biol. 25, 2744–2756.
Girard C, H Neel, E Bertrand and R Bordonne (2006) Depletion of SMN by RNA interference in HeLa cells induces defects in Cajal body formation.Nucl. Acids Res. 34, 2925–2932.
Gubitz AK, W Feng and G Dreyfuss (2004) The SMN complex.Exp. Cell Res. 296, 51–56.
Hayashi M, N Arai, T Murakami, M Yoshio, M Oda and H Matsuyama (1998) A study of cell death in Werdnig Hoffmann disease brain.Neurosci. Lett. 243, 117–120.
He TC, S Zhou, LT da Costa, J Yu, KW Kinzler and B Vogelstein (1998) A simplified system for generating recombinant adenoviruses.Proc. Natl. Acad. Sci. USA 95, 2509–2514.
Hsieh-Li HM, JG Chang, YJ Jong, MH Wu, NM Wang, CH Tsai and H Li (2000) A mouse model for spinal muscular atrophy.Nat. Genetics 24, 66–70.
Iannaccone ST and A Burghes (2002) Spinal muscular atrophies, In:Neuromuscular Disorders (R Pourmand R and Y Harati, Eds.). (Lippincott Williams & Wilkins: Philadelphia, PA).
Ilangovan R, WL Marshall, Y Hua and J Zhou (2003) Inhibition of apoptosis by Z-VAD-fmk in SMN-depleted S2 cells.J. Biol. Chem. 278, 30993–30999.
Jablonka S, B Schrank, M Kralewski, W Rossoll and M Sendtner (2000) Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III.Hum. Mol. Genet. 9, 341–346.
Kerr DA, JP Nery, RJ Traystman, BN Chau and JM Hardwick (2000) Survival motor neuron protein modulates neuron- specific apoptosis.Proc. Natl. Acad. Sci. USA 97, 13312–13317.
Koh JY, MB Wie, BJ Gwag, SL Sensi, LM Canzoniero, J Demaro, C Csernansky and DW Choi (1995) Staurosporineinduced neuronal apoptosis.Exp. Neurol. 135, 153–159.
Kruman, II and MP Mattson (1999) Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis.J. Neurochem. 72, 529–540.
Le TT, LT Pham, ME Butchbach, HL Zhang, UR Monani, DD Coovert, TO Gavrilina, L Xing, GJ Bassell and AH Burghes (2005) SMNΔ7, the major product of the centromeric sur vival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN.Hum. Mol. Genet. 14, 845–857.
Lefebvre S, L Bürglen, S Reboullet, O Clermont, P Burlet, L Viollet, B Benichou, C Cruaud, P Millasseau, M Zevianiet al. (1995) Identification and characterization of a spinal muscular atrophy-determining gene.Cell 80, 155–165.
McWhorter ML, UR Monani, AH Burghes and CE Beattie (2003) Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding.J. Cell Biol. 162, 919–931.
Mercer EA, LKorhonen, Y Skoglosa, PAOlsson, JP Kukkonen and D Lindholm (2000) NAIP interacts with hippocalcin and protects neurons against calcium-induced cell death through caspase-3-dependent and -independent pathways.EMBO J 19, 3597–3607.
Monani UR, DD Coovert and AH Burghes (2000a) Animal models of spinal muscular atrophy.Hum. Mol. Genet. 9, 2451–2457.
Monani UR, M Sendtner, DD Coovert, DW Parsons, C Andreassi TT Le, S Jablonka, B Schrank, W Rossol, TW Prior, GE Morris and AH Burghes (2000b) The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.Hum. Mol. Genet. 9, 333–339.
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.J. Immunol. Meth. 65, 55–63.
Murayama S, TW Bouldin and K Suzuki (1991) Immunocytochemical and ultrastructural studies of Werdnig-Hoffmann disease.Acta Neuropathol. 81, 408–417.
Nielsen KB, S Sørensen, L Cartegni, TJ Corydon, TK Doktor, LD Schroeder, LS Reinert, O Elpeleg, AR Krainer, N Gregersen, J Kjems and BS Andresen (2007) Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer.Am. J. Hum. Genet. 80, 416–432.
Rossoll W, S Jablonka, C Andreassi, AK Kroning, K Karle, UR Monani and M Sendtner (2003) Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of β-actin mRNA in growth cones ofmotoneurons.J. Cell Biol. 163, 801–812.
Schrank B, R Gotz, JM Gunnersen, JM Ure, KV Toyka, AG Smith and M Sendtner (1997) Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos.Proc. Natl. Acad. Sci. USA 94, 9920–9925.
Setola V, M Terao, D Locatelli, S Bassanini, E Garattini and G Battaglia (2007) Axonal-SMN (a-SMN), a protein isoform of the survival motor neuron gene, is specifically involved in axonogenesis.Proc. Natl. Acad. Sci. USA 104, 1959–1964.
Soler-Botija C, I Ferrer, I Gich, M Baiget and EF Tizzano (2002) Neuronal death is enhanced and begins during foetal development in type I spinal muscular atrophy spinal cord.Brain 125, 1624–1634.
Talbot K and KE Davies (2001) Spinal muscular atrophy.Semin. Neurol. 21, 189–197.
Toth G, H Yang, RA Anguelov, J Vettraino, Y Wang and G Acsadi (2002) Gene transfer of glial cell-derived neurotrophic factor and cardiotrophin-1 protects PC 12 cells from injury: involvement of the phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase pathways.J. Neurosci. Res. 69, 622–632.
Trulzsch B, K Davies and M Wood (2004) Survival of motor neuron gene downregulation by RNAi: towards a cell culture model of spinal muscular atrophy.Brain Res. Mol. Brain Res. 120, 145–150.
van Bergeijk J, K Haastert, C Grothe and P Claus (2006) Valproic acid promotes neurite outgrowth in PC 12 cells independent from regulation of the survival of motoneuron protein.Chem. Biol. Drug Design 67, 244–247.
van Bergeijk J, K Rydel-Konecke, C Grothe and P Claus (2007) The spinal muscular atrophy gene product regulates neurite outgrowth: importance of the C terminus.FASEB J. 21, 1492–1502.
Vyas S, C Bechade, B Riveau, J Downward and A Triller (2002) Involvement of survival motor neuron (SMN) protein in cell death.Hum. Mol. Genet. 11, 2751–2764.
Wang W, D Dimatteo, VL Funanage and M Scavina (2005) Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin-induced cell death.Mol. Genet. Metab. 85, 38–45.
Yakovlev AG and AI Faden (2001) Caspase-dependent apoptotic pathways in CNS injury.Mol. Neurobiol. 24, 131–144.
Young PJ, TT Le, N thi Man, AH Burghes and GE Morris (2000) The relationship between SMN, the spinal muscular atrophy protein, and nuclear coiled bodies in differentiated tissues and cultured cells.Exp. Cell Res. 256, 365–374.
Young PJ, TT Le, M Dunckley, TM Nguyen, AH Burghes and GE Morris (2001) Nuclear gems and Cajal (coiled) bodies in fetal tissues: nucleolar distribution of the spinal muscular atrophy protein, SMN.Exp. Cell Res. 265, 252–261.
Young PJ, PM Day, J Zhou, EJ Androphy, GE Morris and CL Lorson (2002) A direct interaction between the survival motor neuron protein and p53 and its relationship to spinal muscular atrophy.J. Biol. Chem. 277, 2852–2859.
Zerres K and S Rudnik-Schoneborn (1995) Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications.Arch. Neurol. 52, 518–523.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Parker, G.C., Li, X., Anguelov, R.A. et al. Survival motor Neuron protein regulates apoptosis in anin vitro model of Spinal muscular atrophy. neurotox res 13, 39–48 (2008). https://doi.org/10.1007/BF03033366
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF03033366